Dendritic cell vaccine for relapsed neuroblastoma patient induces complete remission

One year after his last treatment, a six-year-old boy with recurrent neuroblastoma is in complete remission for his high-risk metastatic cancer.

http://floridabiotechnews.com/cancer/dendritic-cell-vaccine-for-relapsed-neuroblastoma-patient-induces-complete-remission/11948/?#038;#038;